Riverwater Partners’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-101,996
| Closed | -$2.55M | – | 215 |
|
|
2024
Q3 | $2.55M | Buy |
101,996
+86,037
| +539% | +$2.15M | 1.27% | 15 |
|
|
2024
Q2 | $404K | Sell |
15,959
-1,703
| -10% | -$43.1K | 0.3% | 102 |
|
|
2024
Q1 | $449K | Sell |
17,662
-46
| -0.3% | -$1.17K | 0.33% | 87 |
|
|
2023
Q4 | $401K | Buy |
17,708
+111
| +0.6% | +$2.52K | 0.32% | 95 |
|
|
2023
Q3 | $328K | Buy |
17,597
+7,813
| +80% | +$146K | 0.3% | 113 |
|
|
2023
Q2 | $254K | Hold |
9,784
| – | – | 0.23% | 151 |
|
|
2023
Q1 | $281K | Buy |
9,784
+6
| +0.1% | +$172 | 0.26% | 127 |
|
|
2022
Q4 | $289K | Buy |
+9,778
| New | +$289K | 0.25% | 131 |
|
|
2022
Q3 | – | Sell |
-12,466
| Closed | -$278K | – | 189 |
|
|
2022
Q2 | $278K | Buy |
12,466
+96
| +0.8% | +$2.14K | 0.28% | 127 |
|
|
2022
Q1 | $311K | Buy |
12,370
+3,274
| +36% | +$82.3K | 0.51% | 81 |
|
|
2021
Q4 | $326K | Buy |
+9,096
| New | +$326K | 0.29% | 133 |
|